Norihiro Saito

Dr. Norihiro Saito

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2022 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
NSNorihiro Saito
Norihiro Saito
JKJunichi Kitazawa
Junichi Kitazawa
HHHiroko Horiuchi
Hiroko Horiuchi
TYTakeo Yamamoto
Takeo Yamamoto
MKMasahiko Kimura
Masahiko Kimura
HKHiroyuki Kayaba
Hiroyuki Kayaba
Background: Spread of vancomycin-resistant Enterococcus (VRE) is a global concern as a significant cause of healthcare-associated infections. A series of VRE faecium (VREf) outbreaks caused by clonal propagation due to interhospital transmission occurred in six general hospitals in Aomori prefecture, Japan. Methods: The number of patients with VREf was obtained from thirty seven hospitals participating in the local network of Aomori prefecture. Thirteen hospitals performed active screening tests for VRE. Whole genome sequencing analysis was performed. Results: The total number of cases with VREf amounted to 500 in fourteen hospitals in Aomori from Jan 2018 to April 2021. It took more than three years for the frequency of detection of VRE to return to pre-outbreak levels. The duration and size of outbreaks differed between hospitals according to the countermeasures available at each hospital. Whole genome sequencing analysis indicated vanA-type VREf ST1421 for most samples from six hospitals. Conclusions: This was the first multi-jurisdictional outbreak of VREf sequence type 1421 in Japan. In addition to strict infection control measures, continuous monitoring of VRE detection in local medical regions and smooth and immediate communication among hospitals are required to prevent VREf outbreaks.

13 February 2017 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
PDF file
NSNorihiro Saito
Norihiro Saito
AKA. Kamata
A. Kamata
MIM. Itoga
M. Itoga
MTM. Tamaki
M. Tamaki
HKH. Kayaba
H. Kayaba
TRT. Ritz
T. Ritz

13 November 2015 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
NSNorihiro Saito
Norihiro Saito
HKHiroyasu Kamiyama
Hiroyasu Kamiyama
KTKatsumi Takizawa
Katsumi Takizawa
STSeiji Takebayashi
Seiji Takebayashi
TATakeshi Asano
Takeshi Asano
KKKostadin L. Karagiozov
Kostadin L. Karagiozov

1 May 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
NSNorihiro Saito
Norihiro Saito
MIMasamichi Itoga
Masamichi Itoga
SMSatoko Minakawa
Satoko Minakawa
HKHiroyuki Kayaba
Hiroyuki Kayaba
Background: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs) are often used to treat outpatients with psychogenic somatoform symptoms but prove ineffective in some cases. The metabolite 3-hydroxybutyrate (3HB) is currently attracting attention as a marker of the severity of depression. We investigated whether serum 3HB levels in patients with psychogenic somatoform symptoms can predict the effectiveness of sertraline and venlafaxine. Patients and Methods: Physical and psychiatric problems were assessed in 132 outpatients, and symptomatic response and serum 3HB concentrations were examined before and after treatment with sertraline (50 mg/day) or venlafaxine (75 mg/day). Results: In 30.3% of patients with psychogenic symptoms, serum 3HB was above the upper limit of normal (< 80 μmol/L). According to multiple logistic regression analysis, only episodes of suicidal ideation showed a significant positive association with elevated 3HB (odds ratio 10.2; 95% confidence interval (CI) 2.46– 42.2). The sensitivity of 3HB for the effectiveness of sertraline or venlafaxine for psychosomatic symptoms was 44.6%, but specificity was 93.9%. Hierarchical multiple logistic regression analysis identified 3HB as a better predictor of the effectiveness of medication (odds ratio 10.0; 95% CI, 2.49– 40.3) than episodes of suicidal ideation. Conclusion: The present findings suggest that high serum 3HB levels in patients with psychogenic somatoform symptoms may be associated with suicidal ideation and the effectiveness of sertraline and venlafaxine at low to intermediate doses. The 3HB level may be a good predictor of the effectiveness of medication. Examination of serum 3HB levels may lead to earlier and more appropriate administration of sertraline and venlafaxine.

1 January 2006 in Allergology International
Verified
Journal Article
Open access
HOHajime Oyamada
Hajime Oyamada
YKYumiko Kamada
Yumiko Kamada
NSNorihiro Saito
Norihiro Saito
ATAkira Tsuda
Akira Tsuda
OUOsamu Urayama
Osamu Urayama
JCJunichi Chihara
Junichi Chihara
Eosinophils are considered to be the major inflammatory cells in asthma. Since regulated on activation, normal T expressed and secreted (RANTES) is a potent chemoattractant for various important inflammatory cells such as eosinophils as well as memory T cells potentially recruiting these cells to an inflamed focus, RANTES has been considered to play a key role in various allergic disorders such as asthma. To extend our understanding of the participation of eosinophils and T cells in relation to the production of RANTES in response to the specific allergen in asthma, we examined the production of RANTES from peripheral blood mononuclear cells cultured with specific allergen in atopic asthma patients by a sandwich enzyme-linked immunosorbent assay. It was revealed that mononuclear cells produced RANTES but not eotaxin in response to the specific allergen in asthma. RANTES production from mononuclear cells of asthma patients with eosinophilia was greater than that of asthma patients without eosinophilia. Moreover, in this study, no differences in RANTES production between CD4 negative cells and CD8 negative cells were observed. Taken together, these findings may suggest that mononuclear cells play a crucial role in the pathogenesis, particular in eosinophil and T lymphocyte recruitment into the inflamed focus of asthma through RANTES production in response to the specific allergen.

1 January 2014 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
NSNorihiro Saito
Norihiro Saito
HKHiroyasu Kamiyama
Hiroyasu Kamiyama
KTKatsumi Takizawa
Katsumi Takizawa
STSeiji Takebayashi
Seiji Takebayashi
TATakeshi Asano
Takeshi Asano
YIYasuhiro Ito
Yasuhiro Ito
A 55-year-old woman with bilateral vertebral artery (VA) aneurysms was transferred to our hospital. She suffered from a minor stroke. Magnetic resonance imaging (MRI) for the stroke incidentally revealed bilateral VA aneurysms. Due to its size, more observation was recommended, and the patient was found eager to be treated. Both side surgeries were found inappropriate because of severe lower cranial nerve disturbances. The right aneurysm involved the posterior inferior cerebellar artery (PICA) and the V4 segment was deviated to the right side. Therefore, the smaller right aneurysm was treated first with an occipital artery (OA)-PICA bypass and a V3-radial artery graft (RAG)-V4 bypass followed by proximal clipping of the PICA and the right VA. The right VA was successfully remade by RAG and the right aneurysm was not revealed on postoperative examination. By doing so, the opposite aneurysm was able to be eliminated by the parent artery occlusion even by using an interventional radiology (IVR). The V3-RAG-V4 bypass is a useful method for treating bilateral VA aneurysms. This is a new bypass which has not been reported so far to the best of our knowledge.